Intercell Announces FDA Approval of Ixiaro, a Novel Vaccine to Prevent Japanese Encephalitis

Intercell AG today announced that the U.S. FDA approved IXIARO(R), a new vaccine for the prevention of Japanese Encephalitis (JE).

the details can be read here.